Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
365
datasets available to search
ShareScore release 0.9.0
Dataset results
365 results for “Urinary tract infections”
Risk factors for treatment failure in women with uncomplicated lower urinary tract infection
<p><strong>Origin :</strong></p> <p>This dataset represent a sub-population of a previous clinical trial. </p> <blockquote> <p><a href="https://pubmed.ncbi.nlm.nih.gov/29710295/">Huttner A, Kowalczyk A, Harbarth S, et al.. Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial. JAMA. 2018;319(17):1781-1789. DOI: 10.1001/jama.2018.3627.</a></p> </blockquote> <p> </p> <p><strong>Databases : </strong></p> <ul> <li>1st database : women included in the nested cohort study (n=350)</li> <li>2nd database : women with microbiologically conformed UTI (n=279)</li> <li>3d database : women with <em>E.coli</em> related UTI (n=185)</li> </ul> <p><strong>Important : </strong></p> <ul> <li>Data from Tel Aviv have been removed from this dataset, and might be shared by the corresponding author upon reasonable request at the following address (romainmartischang@gmail.com).</li> </ul> <p><strong>Codebook : </strong></p> <ul> <li>v1_XXX; 0/1 : All symptoms present at baseline</li> <li>v1dipstick : Negative (0), nitrites (1), leukocytes esterase (2), both (3), not done (4)</li> <li>centre : recruitment centre (CHE or POL)</li> <li>rfscore : risk factor for carrying a resistant bacteria as defined in the initial trial</li> <li>treatment : nitrofurantoin (0) vs fosfomycin (1)</li> <li>dm : diabetes mellitus </li> <li>case2 : bacteriological failure at 28 days as defined in the initial trial</li> <li>case1 : clinical failure at 28 days as defined in the initial trial</li> <li>recur14 : bacteriological failure at 14 days as defined in the initial trial</li> <li>fail14 : clinical failure at 14 days as defined in the initial trial</li> <li>v1pathogen[1-3] : pathogen present at baseline</li> </ul>
Seven vs. 14 Days Treatment for Male Urinary Tract Infection
ClinicalTrials.gov study NCT01994538. IPD Sharing: YES. Countries: 1. Publications: 1.
Pathogen non-planktonic phases within the urinary tract impact early infection and resistance evolution - Data
<p>This upload contains data that is necessary to re-create the figures for the manuscript "<strong>Infection dynamics in the urinary tract - The importance of non-planktonic phases during early infection and resistance evolution</strong>" by Raatz et al. published in The ISME Journal (<a href="https://doi.org/10.1093/ismejo/wrae191">https://doi.org/10.1093/ismejo/wrae191</a>).</p> <p>This manuscript is available as a bioRxiv preprint at https://www.biorxiv.org/content/10.1101/2023.10.23.563535.</p> <p>The related upload with DOI 10.5281/zenodo.10025282 contains the scripts to compute this data set, as well as the scripts for plotting.</p> <p> </p>
Dataset - Dynamic persistence of intracellular bacterial communities of uropathogenic Escherichia coli in a human bladder-chip model of urinary tract infections
<p>Dataset for manuscript posted at biorxiv: https://doi.org/10.1101/2021.01.03.42483 and in revision for eLife. Data corresponding to each main figure and its associated figure supplements are in seperate .zip folders.</p>
A Biochip for Rapid Diagnosis of Complicated Urinary Tract Infection
ClinicalTrials.gov study NCT00591240. IPD Sharing: NO. Countries: 1. Publications: 2.
A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI)
ClinicalTrials.gov study NCT04020341. IPD Sharing: YES. Countries: 12. Publications: 8.
Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
ClinicalTrials.gov study NCT01345929. IPD Sharing: YES. Countries: 17. Publications: 6.
Nitrofurantoin Administration for the Prevention of Short-Term Catheter Associated Urinary Tract Infection After Pelvic Surgery
ClinicalTrials.gov study NCT03287089. IPD Sharing: NO. Countries: 1. Publications: 21.
Developing a PROM for Recurrent Urinary Tract Infection
ClinicalTrials.gov study NCT05086900. IPD Sharing: NO. Countries: 1. Publications: 1.
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
ClinicalTrials.gov study NCT01595438. IPD Sharing: Not stated. Countries: 22. Publications: 5.
Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017)
ClinicalTrials.gov study NCT03293485. IPD Sharing: YES. Countries: 1. Publications: 1.
GSK2251052 in Complicated Urinary Tract Infection
ClinicalTrials.gov study NCT01381549. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Evaluation of Safety and Efficacy of Intravenous Sulbactam-ETX2514 in the Treatment of Hospitalized Adults With Complicated Urinary Tract Infections
ClinicalTrials.gov study NCT03445195. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in Subjects With Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis
ClinicalTrials.gov study NCT05887908. IPD Sharing: Not stated. Countries: 9. Publications: 0.
Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections
ClinicalTrials.gov study NCT00690378. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Suppressive Therapy With Oral Antibiotics for Prevention of Postoperative Urinary Tract Infection (UTI)
ClinicalTrials.gov study NCT01450800. IPD Sharing: Not stated. Countries: 1. Publications: 11.
Gentamicin Intravesical Efficacy for Infection of Urinary Tract
ClinicalTrials.gov study NCT04246996. IPD Sharing: NO. Countries: 1. Publications: 1.
Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women
ClinicalTrials.gov study NCT01958073. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI)
ClinicalTrials.gov study NCT04187144. IPD Sharing: YES. Countries: 6. Publications: 8.
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
ClinicalTrials.gov study NCT01599806. IPD Sharing: Not stated. Countries: 17. Publications: 6.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.